NFKB1 and mantle cell lymphoma: The cytotoxic effect of bortezomib on established MCL cell lines and MCL-initiating cells was enhanced in the presence of L-type calcium channels inhibitor potentially through a more potent inhibitory effect on the activation of the NF-κB pathway [114].